Demographic and transport characteristics and cardiorespiratory therapies during retrieval of infants with suspected DDCHD and PPHN
| All infants (n=142) | PGE1 group (n=71) | Non-PGE1 (n=71) | p Value* | |
|---|---|---|---|---|
| Demographic data | ||||
| Gestation, median (IQR) | 39 (38–40) | 39 (38–40) | 39 (37–40) | 0.12 |
| Birth weight (g), median (IQR) | 3.3 (2.9–3.8) | 3.5 (2.9–3.7) | 3.3 (2.9–3.8) | 0.50 |
| Transport characteristics | ||||
| Distance (km), median (IQR) | 63 (21–150) | 63 (21–140) | 63 (26–152) | 0.72 |
| Land, n (%) | 101 (71) | 48 (68) | 53 (75) | 0.46 |
| Air, n (%) | 41 (29) | 23 (32) | 18 (25) | 0.46 |
| Duration, hours, mean (SD) | 5.4 (3.1) | 5.9 (3.9) | 4.9 (1.9) | 0.05 |
| Cardiorespiratory therapies | ||||
| Self-ventilating, n (%) | 62 (44) | 33 (46) | 29 (41) | 1.0 |
| CPAP, n (%) | 11 (8) | 4 (6) | 7 (10) | <0.001 |
| IMV, n (%) | 68 (48) | 34 (48) | 34 (48) | 0.85 |
| Fluid bolus, n (%) | 107 (75) | 64 (90) | 43 (61) | <0.01 |
| Inotropes, n (%) | 42 (30) | 22 (31) | 20 (28) | 0.85 |
*PGE1 group compared with noPGE1 group.
CPAP, continuos positive airway pressure; DDCHD, duct dependent congenital heart disease; IMV, intermittent mandatory ventilation; PGE1, prostaglandin E1; PPHN, pulmonary hypertension.